These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 28731583

  • 1. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review.
    Booth J, Connelly L, Dickson S, Duncan F, Lawrence M.
    Neurourol Urodyn; 2018 Feb; 37(2):528-541. PubMed ID: 28731583
    [Abstract] [Full Text] [Related]

  • 2. Transcutaneous tibial nerve electrical stimulation versus vaginal electrical stimulation in women with overactive bladder syndrome: Is there a role for short-term interventions?
    Nunes JMO, Gregório EP, Moreira ECH, Hazime FA, Averbeck MA, de Almeida SHM.
    Neurourol Urodyn; 2023 Jun; 42(5):1101-1110. PubMed ID: 37042223
    [Abstract] [Full Text] [Related]

  • 3. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.
    Ghijselings L, Renson C, Van de Walle J, Everaert K, Spinoit AF.
    Trials; 2021 Apr 02; 22(1):247. PubMed ID: 33810804
    [Abstract] [Full Text] [Related]

  • 4. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome.
    Ramírez-García I, Kauffmann S, Blanco-Ratto L, Carralero-Martínez A, Sánchez E.
    Neurourol Urodyn; 2021 Jan 02; 40(1):295-302. PubMed ID: 33118624
    [Abstract] [Full Text] [Related]

  • 5. Effects of transcutaneous tibial nerve stimulation on females with overactive bladder syndrome in multiple sclerosis a protocol for a systematic review and meta-analysis.
    Tu H, Li N, Liu W, Fan Z, Kong D.
    PLoS One; 2022 Jan 02; 17(7):e0269371. PubMed ID: 35901036
    [Abstract] [Full Text] [Related]

  • 6. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M, Crampton J.
    Physiotherapy; 2019 Dec 02; 105(4):469-475. PubMed ID: 30862384
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial.
    Sonmez R, Yildiz N, Alkan H.
    Ann Phys Rehabil Med; 2022 Jan 02; 65(1):101486. PubMed ID: 33429090
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta-analysis.
    Ghavidel-Sardsahra A, Ghojazadeh M, Rahnama'I MS, Naseri A, Yazdandoost S, Khezerloo T, Seyedi-Sahebari S, Hosseinifard H, Vahed N, Mostafaei H, Salehi-Pourmehr H, Hajebrahimi S.
    Neurourol Urodyn; 2022 Feb 02; 41(2):539-551. PubMed ID: 35032328
    [Abstract] [Full Text] [Related]

  • 9. Transcutaneous Tibial Nerve Stimulation in the Management of Overactive Bladder: A Scoping Review.
    Sayner AM, Rogers F, Tran J, Jovanovic E, Henningham L, Nahon I.
    Neuromodulation; 2022 Dec 02; 25(8):1086-1096. PubMed ID: 35688702
    [Abstract] [Full Text] [Related]

  • 10. Comparative Efficacy of Neuromodulation Technologies for Overactive Bladder in Adults: A Network Meta-Analysis of Randomized Controlled Trials.
    Huang J, Fan Y, Zhao K, Yang C, Zhao Z, Chen Y, Yang J, Wang T, Qu Y.
    Neuromodulation; 2023 Dec 02; 26(8):1535-1548. PubMed ID: 35989159
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transcutaneous tibial nerve stimulation versus parasacral stimulation in the treatment of overactive bladder in elderly people: a triple-blinded randomized controlled trial.
    Jacomo RH, Alves AT, Lucio A, Garcia PA, Lorena DCR, de Sousa JB.
    Clinics (Sao Paulo); 2020 Dec 02; 75():e1477. PubMed ID: 31939564
    [Abstract] [Full Text] [Related]

  • 14. Comparison of transcutaneous tibial nerve stimulation (TTNS) protocols for women with refractory overactive bladder (OAB): A prospective randomised trial.
    Alkis O, Sevim M, Güven Kartal İ, Baser A, İbrahim İvelik H, Aras B.
    Int J Clin Pract; 2021 Sep 02; 75(9):e14342. PubMed ID: 33966335
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of Transcutaneous and Percutaneous Tibial Nerve Stimulation in Bosnian Female Patients with an Idiopathic Overactive Urinary Bladder.
    Zonić-Imamović M, Sinanović O, Imamović M, Muftić M, Janković S, Bazardžanović M.
    Acta Med Acad; 2021 Aug 02; 50(2):235-243. PubMed ID: 34847676
    [Abstract] [Full Text] [Related]

  • 17. Transcutaneous Tibial Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Pilot Study for an International Multicenter Randomized Controlled Trial.
    Tornic J, Liechti MD, Stalder SA, Birkhäuser V, van der Lely S, Leitner L, Mehnert U, Kessler TM.
    Eur Urol Focus; 2020 Sep 15; 6(5):909-915. PubMed ID: 31810854
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Self-management of overactive bladder at home using transcutaneous tibial nerve stimulation: a qualitative study of women's experiences.
    Daly CME, Loi L, Booth J, Saidan D, Guerrero K, Tyagi V.
    BMC Womens Health; 2021 Oct 27; 21(1):374. PubMed ID: 34706709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.